BCLI
BRAINSTORM CELL THERAPUTC
BCLI
BCLI
Delisted
BCLI was delisted on the 17th of July, 2025.
24 hedge funds and large institutions have $3.14M invested in BRAINSTORM CELL THERAPUTC in 2016 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
96% less call options, than puts
Call options by funds: $4K | Put options by funds: $98K
Holders
24
Holding in Top 10
–
Calls
$4K
Puts
$98K
Top Buyers
| 1 | +$189K | |
| 2 | +$51K | |
| 3 | +$39.6K | |
| 4 |
Wells Fargo
San Francisco,
California
|
+$10K |
| 5 |
DOA
D'Orazio & Associates
Falls Church,
Virginia
|
+$2K |
Top Sellers
| 1 | -$964K | |
| 2 | -$77K | |
| 3 | -$13K | |
| 4 |
Bank of New York Mellon
New York
|
-$6.01K |